Condition
Recurrent Nasopharyngeal Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Recurrent Nasopharyngeal Squamous Cell Carcinoma clinical trials that are recruiting, in United States. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1Country
Newest Recurrent Nasopharyngeal Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Autologous tumor membrane vesicle (TMV) vaccine alone or with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma | Phase 1 | Atlanta, Georgia and 1 other locations | Recruiting | Mar 11, 2025 |
| Remote hearing tests for patients with head and neck cancer receiving chemotherapy or radiation | — | Atlanta, Georgia | Recruiting | Oct 28, 2024 |
| Combining lovastatin and pembrolizumab for advanced head and neck cancer treatment | Phase 2 | Atlanta, Georgia and 1 other locations | Recruiting | Oct 15, 2024 |
All recruiting trials (3)
-
Autologous tumor membrane vesicle (TMV) vaccine alone or with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
This trial tests whether a vaccine made from a patient's own tumor (TMV), given alone or with pembrolizumab, can help people with recurrent or metastatic head and neck squamous cell carcinoma who had tumor tissue banked at surgery.
-
Remote hearing tests for patients with head and neck cancer receiving chemotherapy or radiation
This study is testing if remote hearing tests can help patients with advanced head and neck cancer keep track of their hearing loss during chemotherapy or radiation, making it easier for those who live far away to participate.
-
Combining lovastatin and pembrolizumab for advanced head and neck cancer treatment
This study is testing if combining a cholesterol-lowering drug called lovastatin with an immunotherapy drug called pembrolizumab can help people with advanced head and neck cancer feel better and live longer.
Related topics
Quick answers
How many Recurrent Nasopharyngeal Squamous Cell Carcinoma clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.